Trends in Endocrinology & Metabolism
ReviewMechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery
Section snippets
Bariatric surgery
The obesity pandemic has become a global burden and is now a leading cause of morbidity and mortality. To date, non-surgical means of weight reduction have been ineffective in producing sustained weight loss. Currently, bariatric surgery is the most effective treatment for obesity and is indicated for patients with a body mass index (BMI) >40 kg/m2, or for individuals with a BMI >35 kg/m2 and significant obesity-related comorbidities. A range of different bariatric procedures are available, some
Bariatric procedures
Bariatric procedures are divided into three categories: restrictive, malabsorptive and hybrid procedures, the latter combining gastric restriction and malabsorption (Figure 1). Restrictive procedures, such as gastric banding (GB), vertical banded gastroplasty (VBG) and sleeve gastrectomy (SG) reduce gastric volume (Figure 1). GB entails inserting a synthetic band with an inner inflatable balloon around the stomach below the gastro-oesophageal junction. The inner balloon diameter and hence the
Malabsorption
In 1954 Kremen et al. reported that surgical bypass of the distal small intestine in dogs reduced food absorption and resulted in weight loss. Consequently, they advocated intestinal bypass surgery as a treatment for human obesity [8], the rationale being that reduced nutrient absorption results in weight loss. However, as early as 30 years ago, studies indicated that malabsorption was not the major cause of weight loss in patients that had undergone intestinal bypass surgery [9]. For example,
Gut hormones and bariatric surgery
The gut is the largest endocrine organ in the body, producing hormones that have important sensing and signalling roles in the regulation of appetite and energy homeostasis. Bariatric surgical procedures alter the circulating concentrations of several gut hormones, including GLP-1, PYY and ghrelin. So far, reports of the effect of different surgical procedures on all three hormones have been controversial. Differences in surgical techniques, research methodologies, sample assays and blood
GLP-1 levels after bariatric surgery
GLP-1 is a peptide synthesised by the L-cells of the distal gut and released in response to nutrient ingestion [27]. The main physiological action of GLP-1 is stimulation of glucose-dependent insulin secretion [27]. In addition, GLP-1 exhibits appetite and body weight regulatory properties 29, 30, 31 (Box 1).
The first observations that circulating GLP-1 levels increase after bariatric surgery were made three decades ago. In the late 1970 s, Barry et al. reported elevated enteroglucagon levels
PYY levels after bariatric surgery
PYY is a peptide hormone synthesised by the L-cells of the distal gastrointestinal tract and released in response to food ingestion [21]. PYY suppresses appetite and exerts regulatory properties on body weight and glucose homeostasis [21]. Two forms of the peptide have been described: total PYY1-36 and PYY3-36 [21] (Box 2).
As both GLP-1 and PYY are secreted by the L-cells of the distal gut, it is no surprise that postoperative levels of the peptides parallel one another. The first observation
Ghrelin as a mediator of weight loss and T2DM resolution following bariatric surgery
Ghrelin is a unique orexigenic hormone released from the stomach in response to nutrient ingestion [21]. Additional properties of ghrelin include a regulatory role in body weight, energy and glucose homeostasis [21] (Box 3). Ghrelin undergoes post-translational acylation which is necessary for its conversion to its active form, acyl-ghrelin [21] (Box 3). Several studies have assessed the impact of bariatric surgery on circulating ghrelin profiles, measuring either total (acyl- and
Concluding remarks
Weight loss and resolution of T2DM after bariatric surgery appear to be the composite outcome of multiple contributing mechanisms. Current evidence suggests that the key mechanism behind the weight loss and metabolic beneficial effects is increased hindgut stimulation due to enhanced nutrient delivery and subsequent exaggerated release of hindgut hormones, such as GLP-1 and PYY. Future studies in transgenic mice and humans evaluating alterations in gut hormones after bariatric surgery and the
Acknowledgments
We would like to thank Karima Yousseif for the illustrations. A.Y. is funded by the UCL/UCLH Comprehensive Biomedical Centre. We apologise to those authors whose original papers could not be cited because of space constraints.
Glossary
- Body mass index (BMI)
- a measure of a person's weight in relation to their height, it is used to estimate body fat. BMI is calculated by dividing body weight (in kilograms) by the square of height (in metres). Normal BMI is defined as 18–24.9 kg/m2, overweight as BMI 25–29.9 kg/m2 and obesity as BMI >30 kg/m2.
- Entero–entero anastomosis
- an anastomosis between two pieces of intestine.
- Foregut
- the anterior portion of the alimentary tract. For the purpose of this review, the term foregut refers to the
References (78)
Long- or short-limb gastric bypass?
J. Gastrointest. Surg.
(2001)- et al.
Gastric bypass in obesity
Surg. Clin. North Am.
(1967) The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats
Physiol. Behav.
(1984)First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve
Surg. Obes. Relat. Dis.
(2008)Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism
J. Gastrointest. Surg.
(2009)Subject standardization, acclimatization and sample processing affect gut hormone levels and appetite in humans
Gastroenterology
(2009)Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding
Surg. Obes. Relat. Dis.
(2007)Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery
Am. J. Clin. Nutr.
(2006)- et al.
Biology of incretins: GLP-1 and GIP
Gastroenterology
(2007) Critical role for peptide YY in protein-mediated satiation and body-weight regulation
Cell Metab.
(2006)
PYY transgenic mice are protected against diet-induced and genetic obesity
Neuropeptides
Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease
Ann. Surg.
Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution
J. Clin. Endocrinol. Metab.
Bariatric surgery: a systematic review and meta-analysis
J. Am. Med. Assoc.
Long-term results of jejunoileal bypass in the young
Am. Surg.
An experimental evaluation of the nutritional importance of proximal and distal small intestine
Ann. Surg.
Effects of intestinal bypass surgery on appetite, food intake and body weight in obese and lean rats
Am. J. Physiol.
Appetitive behavior after jejunoileal bypass
Int. J. Obes.
A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity
Ann. Surg.
Appetitive behavior after gastric bypass for obesity
Int. J. Obes.
Gastric bypass and vertical banded gastroplasty – a prospective randomized comparison and 5-year follow-up
Obes. Surg.
Bariatric surgery and long-term control of morbid obesity
J. Am. Med. Assoc.
Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus
J. Clin. Endocrinol. Metab.
Gastrointestinal surgery as a treatment for diabetes
J. Am. Med. Assoc.
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial
J. Am. Med. Assoc.
Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes
Diabetes Care
Glucagon-like peptides: regulators of cell proliferation, differentiation and apoptosis
Mol. Endocrinol.
PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet
Diabetes
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats
Am. J. Physiol. Endocrinol. Metab.
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model
Obes. Surg.
Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1
Ann. Surg.
A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years
Obes. Surg.
The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat
Endocrinology
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes
Ann. Surg.
An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity
Obesity (Silver Spring)
Cited by (99)
Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort
2024, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsGlucokinase activity in diabetes: too much of a good thing?
2023, Trends in Endocrinology and MetabolismGastric Bypass Regulates Early Inflammatory Responses in High-Fat Diet-Induced Obese Mice
2022, Journal of Surgical ResearchComparative Effectiveness of Roux-en Y Gastric Bypass Versus Vertical Sleeve Gastrectomy for Sustained Remission of Type 2 Diabetes Mellitus
2021, Journal of Surgical ResearchCitation Excerpt :There are various hypothesized mechanisms by which bariatric surgery leads to improvement in glucose homeostasis. The 3 major contributors are weight loss, nutrient malabsorption, and gut hormonal changes; no one mechanism completely explains the effect of metabolic surgery on improvement in glucose homeostasis.15 Gastric volume restriction procedures lead to weight loss leading to improvement in hepatic insulin sensitivity and clearance resulting in lowering of fasting glucose levels, and caloric restriction reduces hyperinsulinemia and allows pancreatic beta cells to rest, resulting in enhanced beta cell function.11
Weight Loss after Left Gastric Artery Embolization: A Systematic Review and Meta-Analysis
2019, Journal of Vascular and Interventional Radiology